Mar 12 |
Spero Therapeutics Q4 2023 Earnings Preview
|
Mar 6 |
Spero Therapeutics to Provide Business Update and Report Fourth Quarter and Full Year 2023 Financial Results on Wednesday, March 13, 2024
|
Feb 28 |
Spero Therapeutics Announces Clearance of IND for SPR206 to Treat MDR Gram-negative Bacterial Infections
|
Feb 26 |
Spero Therapeutics to Present at Cowen’s 44th Annual Healthcare Conference
|
Feb 6 |
Spero Therapeutics Inc CEO Sath Shukla Sells 75,994 Shares
|
Jan 29 |
15 Cash-Rich Penny Stocks Hedge Funds Are Buying
|
Jan 25 |
11 Hyper-Growth Stocks Billionaires Are Loading Up On
|
Jan 19 |
Spero Therapeutics, Inc. (NASDAQ:SPRO): Are Analysts Optimistic?
|
Jan 5 |
Spero Therapeutics says cash and cash equivalents as of December 31 were about $76.3M
|
Jan 5 |
Spero Therapeutics Provides Corporate Update and 2024 Outlook
|